Detalles de la búsqueda
1.
A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria.
Virus Evol
; 3(Suppl 1)2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28845272
2.
Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20100990
3.
SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-491004
4.
Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-422555
5.
Age-related heterogeneity in Neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251054
6.
Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249840
7.
Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20241927
8.
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-443253
Resultados
1 -
8
de 8
1
Próxima >
>>